openPR Logo
Press release

Eisenmenger Syndrome Treatment Market Will Exhibit an Impressive Expansion by 2024-2031

04-17-2024 04:05 PM CET | Health & Medicine

Press release from: Orion Market Research

Eisenmenger Syndrome Treatment Market Will Exhibit

The global eisenmenger syndrome treatment market is anticipated to grow at a CAGR during the forecast period. The triad of systemic-to-pulmonary congenital cardiovascular communication, pulmonary arterial disease, and cyanosis is called Eisenmenger syndrome. The major factor that drives the market is consistent regulatory approval to the key players operating in the global market for the treatment of Eisenmenger syndrome by providing drugs, and therapy is expected to drive the market growth. For instance-

July 2021- The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the US Food and Drug Administration (FDA) has approved UPTRAVI (selexipag) injection for intravenous (IV) use for the treatment of pulmonary arterial hypertension in adult patients with WHO functional class (FC) II-III, who are temporarily unable to take oral therapy. UPTRAVI IV is a therapeutic option that will allow patients to avoid short-term treatment interruptions and stay on UPTRAVI therapy, as uninterrupted treatment is considered key for individuals with PAH.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/eisenmenger-syndrome-treatment-market

April 2021- The US FDA has granted a second approval to treprostinil (Tyvaso) inhalation solution, for the patines. Tyvaso DPI is the only therapy approved by the FDA for PH-ILD, when the blood pressure in the lungs is high due to a disease that causes lung scarring. Moreover, the convenience and portability of Tyvaso DPI make it an important new option for patients with WHO Group 1 PAH and with WHO Group 3 PH-ILD, with the potential for improving the quality of life for this patient population.

Global Eisenmenger Syndrome Treatment Market- Segmentation

By Drug Type

• Antiarrhythmic Agents
• Blood Thinning Agents
• Endothelin Receptor Antagonist
• Others

By Diagnosis

• Blood tests
• Electrocardiogram (ECG)
• Chest X-ray
• Echocardiogram
• Computerized tomography (CT) scan
• Magnetic resonance imaging (MRI)
• Cardiac catheterization

By Distribution Channel

• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies

A full report of Eisenmenger Syndrome Treatment Market is available at: https://www.omrglobal.com/industry-reports/eisenmenger-syndrome-treatment-market

Eisenmenger Syndrome Treatment Market- Segment by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• Eli Lilly and Co.
• Gilead Sciences, Inc.
• GlaxoSmithKline
• Hikma Pharmaceuticals PLC
• Lupin Ltd.
• Merck & Co., Inc.
• Natco Pharma Ltd.
• Sun Pharma
• Viatris Inc
• Zydus Pharmaceuticals (USA) Inc.

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.


Visit more report at

https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/

https://www.linkedin.com/pulse/aesthetic-threads-market-increasing-demand-growth-2031-vishwakarma-pyg5f

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Eisenmenger Syndrome Treatment Market Will Exhibit an Impressive Expansion by 2024-2031 here

News-ID: 3467622 • Views:

More Releases from Orion Market Research

US Geriatric Medicine Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
US Geriatric Medicine Market Size, Trends, Latest Insights, Analysis and Forecas …
The US geriatric medicine market is projected to grow at a CAGR of 4.6% during the forecast period. The US has high per capita income; access to advanced healthcare, a large elderly population, and a high prevalence of chronic diseases are some of the major factors driving the geriatric medicine market in the country. Moreover, a significant presence of key market players, such as Pfizer Inc., Bristol-Myers Squibb Co., Abbott Laboratories
Urometer Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Urometer Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
The global urometer market is anticipated to grow at a considerable CAGR of 6.9% during the forecast period. The increasing cases of prostate cancer are expected to propel the growth of the global urometer market. Other than skin cancer, prostate cancer is the most common cancer in the US. According to the American Cancer Society (ACS), as of March 2022, around 268,490 new cases of prostate cancer and around
Urethral Dilators Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Urethral Dilators Market Size, Trends, Latest Insights, Analysis and Forecast 20 …
The global urethral dilators market is anticipated to grow at a considerable CAGR of 4.9% during the forecast. The growing incidence of Healthcare-Acquired Infections (HAI) is Boosting the Global Urethral Dilators Market. These are infections that patients get while receiving treatment for medical or surgical conditions. These infections can be occurred in hospitals, surgical centers, ambulatory clinics, and long-term care facilities such as nursing homes and rehabilitation facilities. To
Transvaginal Endoscopy Market Will Exhibit an Impressive Expansion by 2024-2031
Transvaginal Endoscopy Market Will Exhibit an Impressive Expansion by 2024-2031
The global transvaginal endoscopy market is anticipated to grow at a significant CAGR of 7.3% during the forecast period. Some of the prominent factors driving the market growth during the forecast period include the rising incidence of infertility among the female rising incidence of infertility globally, coupled with the increasing use of minimally invasive surgery. The MIS procedures involves minminal use of surgical incisions, and with the advent of laproscopic

All 5 Releases


More Releases for Eisenmenger

Nutraceutical Product Market Size, Share, Statistics, Trends, Competitive analys …
The most recent study offered by Acumen Research and Consulting focuses Nutraceutical Product Market size, share, growth rate, and market trends, as well as the parameters and factors influencing it in both the long term and short term. The report investigates the Nutraceutical Product Market trends in order to assess its current and future potential. Our Nutraceutical Product Market analysis also provides market participants and new entrants with a comprehensive
Custom Procedure Packs Market value is set to grow by USD 15.1 Billion from 2022 …
The most recent study offered by Acumen Research and Consulting focuses Custom Procedure Packs Market size, share, growth rate, and market trends, as well as the parameters and factors influencing it in both the long term and short term. The report investigates the Custom Procedure Packs Market trends in order to assess its current and future potential. Our Custom Procedure Packs Market analysis also provides market participants and new entrants
Antidiabetics Market Market: Global Opportunity Analysis, market share, SWOT and …
The most recent study offered by Acumen Research and Consulting focuses Antidiabetics Market size, share, growth rate, and market trends, as well as the parameters and factors influencing it in both the long term and short term. The report investigates the Antidiabetics Market trends in order to assess its current and future potential. Our Antidiabetics Market analysis also provides market participants and new entrants with a comprehensive view of the
Eisenmenger Syndrome Treatment Market Share, Industry Dynamics, Global Trends an …
The exclusive research report on 'Eisenmenger Syndrome Treatment Market' now available with 𝐂𝐨𝐡𝐞𝐫𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, offers a detailed analysis of the factors influencing the global business sphere. This report also provides precise information pertaining to market size, commercialization aspects and revenue estimation of this business. The report further elucidates the status of leading industry players thriving in the competitive spectrum of the Eisenmenger Syndrome Treatment Market. The research report incorporates a
Eisenmenger Syndrome Treatment Market Size will Grow Profitably in the Near Futu …
Global Eisenmenger Syndrome Treatment Market: Introduction The triad of congenital systemic-to-pulmonary communication, cyanosis, and pulmonary arterial disease is called Eisenmenger syndrome. Eisenmenger syndrome is caused due to a birth defect. The disease is characterized by high blood pressure and abnormal blood flow through the heart. The specific symptoms of Eisenmenger syndrome vary greatly from person to person. The most notable symptom is called cyanosis, which is the bluish discoloration of the
Eisenmenger Syndrome Treatment Market Analysis with Forecast By Leading Key Play …
Eisenmenger Syndrome develops due to high blood pressure in the lungs, which is known as pulmonary hypertension. Pulmonary hypertension occurs due to certain congenital heart defects that cause the blood to flow from left side of the heart to right side abnormally (left-to-right shunt). The congenital heart defects causing this condition include Patent ductus arteriosus (PDA), atrial septal defect (ASD), Ventricular septal defect (VSD), and Atrioventricular canal defect (AV canal).